Evidence map›Paper›PMID 33665882›Full record

ArticleCancer science2021

Histological sequence of the development of rat mesothelioma by MWCNT, with the involvement of apolipoproteins.

Motoki Hojo, Yukio Yamamoto, Yoshimitsu Sakamoto, Ai Maeno, Aya Ohnuki, Jin Suzuki, Akiko Inomata, Takako Moriyasu, Yuhji Taquahashi, Jun Kanno and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. In vivo genotoxicity assessment of a multiwalled carbon nanotube in a mouse ex vivo culture.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Motoki HojoDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5386-5110
Yukio YamamotoDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Yoshimitsu SakamotoDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Ai MaenoDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Aya OhnukiDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Jin SuzukiDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Akiko InomataDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Takako MoriyasuDepartment of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Yuhji TaquahashiCenter for Biological Safety and Research, National Institute of Health Sciences, Kanagawa, Japan.
Jun KannoCenter for Biological Safety and Research, National Institute of Health Sciences, Kanagawa, Japan.
Akihiko HiroseCenter for Biological Safety and Research, National Institute of Health Sciences, Kanagawa, Japan.
Dai NakaeDepartment of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5895-3830
Tokyo Metropolitan Institute of Public Health · JPNational Institute of Occupational Safety and Health · JPTokyo University of Agriculture · JP

Funding

Ministry of Health, Labour and Welfare H27-Kagaku-Shitei-004Ministry of Health, Labour and Welfare H30-Kagaku-Shitei-004
6 · The paper itself

Abstract

A rat model of mesothelioma development by peritoneal injection of multiwalled carbon nanotube (MWCNT) has been established and found to be useful to understand the mechanisms underlying fibrous particles-associated carcinogenesis. Its detailed histological sequence, however, remains largely obscure. We therefore aimed to assess the time-course of mesothelioma development by MWCNT and evaluate a set of lipoprotein-related molecules as potential mechanism-based biomarkers for the phenomenon. Male Fischer 344 rats were injected intraperitoneally (ip) with MWCNT (MWNT-7) at 1 mg/kg body weight, and necropsied at 8, 16, 24, 32, or 42 wk after injection. For biochemical analyses of the lipoprotein-related molecules, more samples, including severe mesothelioma cases, were obtained from 2 other carcinogenicity tests. Histologically, in association with chronic inflammation, mesothelial proliferative lesions appeared at c. Wk-24. Before and at the beginning of the tumor development, a prominent infiltration of CD163-positive cells was seen near mesothelial cells. The histological pattern of early mesothelioma was not a papillary structure, but was a characteristic structure with a spherical appearance, composed of the mesothelioma cells in the surface area that were underlain by connective tissue-like cells. Along with the progression, mesotheliomas started to show versatile histological subtypes. Serum levels of apolipoprotein A-I and A-IV, and a ratio of HDL cholesterol to total cholesterol were inversely correlated with mesothelioma severity. Overall, the detailed histological sequence of mesotheliomagenesis by MWCNT is demonstrated, and indicated that the altered profile of apolipoproteins may be involved in its underlying mechanisms.

Indexed as

AnimalsApolipoproteinsAscitic FluidBiomarkers, TumorCarcinogenesisCarcinogensCholesterolMaleMesotheliomaNanotubes, CarbonRatsRats, Inbred F344ApolipoproteinsBiomarkers, TumorCarcinogensCholesterolNanotubes, CarbonapolipoproteincholesterolMWCNTperitoneal mesotheliomarat

Identifiers

PMID33665882
PMCPMC8177772
OpenAlexW3134087268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.